Status:
RECRUITING
Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Uveal Melanoma
Eligibility:
All Genders
Brief Summary
Uveal melanoma is the most common primary intraocular tumor in adults. The local treatment is effective, but patients still die of metastatic disease. It has been shown that early diagnosis of a few i...
Eligibility Criteria
Inclusion
- diagnosis of uveal melanoma
Exclusion
- refusal to participate in the study
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2040
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT01438658
Start Date
September 1 2011
End Date
December 1 2040
Last Update
September 28 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Specialized Ocular Oncology Service, Hadassah-Hebrew-University Medical Center
Jerusalem, Israel, 91120